Core Viewpoint - The company has announced a cash dividend of 0.06 yuan per share, approved at the 2024 annual general meeting held on May 23, 2025 [1][2]. Dividend Distribution Plan - The dividend distribution is based on the total share capital minus shares held in the company's repurchase account, with a total of 399,441,300 shares eligible for distribution [2][4]. - The total cash dividend to be distributed amounts to 23,966,478.00 yuan (including tax) [2]. - The company will not issue bonus shares or capital reserves, and the distribution will only involve cash dividends [2][4]. Implementation Method - Cash dividends will be distributed through China Securities Depository and Clearing Corporation Limited Shanghai Branch to shareholders registered by the end of the trading day on the record date [5]. - Shareholders who have completed designated transactions can receive their cash dividends on the payment date, while those who have not will have their dividends held until they complete the necessary transactions [5]. Taxation Information - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.06 yuan per share [8]. - For shares held for less than one year, the company will not withhold personal income tax at the time of distribution, but tax will be calculated and deducted upon the sale of shares [8]. - Qualified Foreign Institutional Investors (QFIIs) will have a 10% corporate income tax withheld, resulting in a net distribution of 0.054 yuan per share [9].
成都先导药物开发股份有限公司2024年年度权益分派实施公告